MassMutual Private Wealth & Trust’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIK
CWP
VCM
GI
FFA
TWD
GIA
FFO
MassMutual Private Wealth & Trust's ANIK Position: Q2 2026 in Review
MassMutual Private Wealth & Trust held its Anika Therapeutics (ANIK) position steady in Q2 2026 at 159 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.
MassMutual Private Wealth & Trust first reported a position in ANIK in Q2 2018 and has held it in 27 quarters since. The position peaked at $200K in Q4 2019. 10 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.
- MassMutual Private Wealth & Trust held 159 shares of Anika Therapeutics worth $2.33K as of Q2 2026.
- MassMutual Private Wealth & Trust left its Anika Therapeutics share count unchanged in Q2 2026.
- Anika Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1959 holding.
- MassMutual Private Wealth & Trust first reported a position in Anika Therapeutics in Q2 2018 and has held it in 27 quarters since.
- MassMutual Private Wealth & Trust's Anika Therapeutics position peaked at $200K in Q4 2019.
- 10 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.